Novo Nordisk Supports Four San Francisco-based Organizations In Fight Against
$80,000 in Sponsorships awarded, aimed at helping San Francisco residents
living with type 2 diabetes
SAN FRANCISCO, Nov. 15, 2012
SAN FRANCISCO, Nov. 15, 2012 /PRNewswire/ --Novo Nordisk, a world leader in
diabetes care, announced today that it has awarded $80,000 in sponsorships to
four San Francisco community organizations. The San Francisco sponsorships are
part of the nationwide Novo Nordisk Community Care initiative to help rally
communities to address the diabetes crisis and support local programs designed
to make an impact for people living with type 2 diabetes. According to data
commissioned by Novo Nordisk from the Institute of Alternative Futures, as of
2010, San Francisco had more than 433,000 people with diagnosed and
undiagnosed diabetes and an additional 1.1 million people in danger of
Novo Nordisk convened two community leaders to help evaluate the many
innovative programs that were presented for sponsorship – Marlene Bedrich,
RNC, MS, CDE at the Diabetes Teaching Center at UCSF and Jeffrey Manese,
Physician Assistant at the Kapla Medical Group. Programs that received funding
were considered to be the most creative, impactful, and meaningful for the
community and took an innovative approach to addressing type 2 diabetes.
"We know from research that type 2 diabetes has far-reaching impact in San
Francisco and that local organizations play a critical role in addressing the
problem through programs that understand the local population," said Bedrich.
"By providing support to incubate innovative programs on a local level, Novo
Nordisk is providing an important resource to help address the diabetes
epidemic in San Francisco."
Organizations that received sponsorships target a range of diverse communities
in San Francisco and include:
oDance Out Diabetes – They will expand their "Dance Out Diabetes Cash and
Care for Wellness" program with new diabetes education workshops and dance
offerings in San Francisco County communities.
oLIFT – Levantate – Through the sponsorship, their Adult Diabetes
Management Project will offer diabetes education to multicultural
populations and train community health advocates in Bay Area communities
such as Marin City, Novato, the Canal area of San Rafael, San Francisco
(Portola), Richmond, and San Leandro.
oNorthern California Center for Well-Being – Their "Live Well Type 2
Diabetes Peer Mentor" program will train peer mentors to serve as health
coaches and teach people living with diabetes how to properly manage the
oNorth East Medical Services – NEMS will offer Stanford University Patient
Education Center's "Diabetes Self Management Program" in various Chinese
languages at its seven area clinics.
"Novo Nordisk is proud to partner with each of these San Francisco
organizations for their innovative approach to diabetes education in their
local community," said Lori Moore, Executive Director of Communications and
Public Affairs at Novo Nordisk. "It is our hope that through Community Care,
Novo Nordisk can help local organizations around the country develop impactful
programs that will have a lasting effect on the epidemic of type 2 diabetes."
In 2011, Novo Nordisk Community Care sponsored more than 20 diverse
community-based programs and awarded $415,000 to organizations in Atlanta,
Minneapolis, Boston, and Philadelphia. In addition to San Francisco, in 2012,
Novo Nordisk is offering new sponsorship opportunities to eligible
organizations in the Houston, Detroit, and Milwaukee/Madison metropolitan
areas where diabetes is a heavy burden on the community. In these areas, the
Novo Nordisk Community Care initiative aims to activate and enable
organizations that are ambassadors for change in diabetes care and are making
an impact in their local communities. For more information about Novo Nordisk
Community Care, visit www.novonordisk-us.com/communitycare.
About Novo Nordisk
Headquartered in Denmark, Novo Nordisk is a global healthcare company with 89
years of innovation and leadership in diabetes care. The company also has
leading positions within hemophilia care, growth hormone therapy, and hormone
replacement therapy. For more information, visit novonordisk-us.com.
SOURCE Novo Nordisk
Contact: Tanya Wymer, Novo Nordisk, Office: +1-609-987-4266
Press spacebar to pause and continue. Press esc to stop.